Metcalfe DD - Search Results

1

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis.

Arock M, Wedeh G, Hoermann G, Bibi S, Akin C, Peter B, Gleixner KV, Hartmann K, Butterfield JH, Metcalfe DD, Valent P. Arock M, et al. Among authors: metcalfe dd. Haematologica. 2018 Nov;103(11):1760-1771. doi: 10.3324/haematol.2018.195867. Epub 2018 Jul 5. Haematologica. 2018. PMID: 29976735 Free PMC article. Review.

2

Fas (CD95, APO-1) antigen expression and function in murine mast cells.

Hartmann K, Wagelie-Steffen AL, von Stebut E, Metcalfe DD. Hartmann K, et al. Among authors: metcalfe dd. J Immunol. 1997 Oct 15;159(8):4006-14. J Immunol. 1997. PMID: 9378990

3

Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells.

Wagelie-Steffen AL, Hartmann K, Vliagoftis H, Metcalfe DD. Wagelie-Steffen AL, et al. Among authors: metcalfe dd. Immunology. 1998 Aug;94(4):569-74. doi: 10.1046/j.1365-2567.1998.00559.x. Immunology. 1998. PMID: 9767446 Free PMC article.

4

Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis.

Worobec AS, Akin C, Scott LM, Metcalfe DD. Worobec AS, et al. Among authors: metcalfe dd. J Allergy Clin Immunol. 1998 Sep;102(3):523-4. doi: 10.1016/s0091-6749(98)70144-7. J Allergy Clin Immunol. 1998. PMID: 9768597 No abstract available.

5

Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.

Akin C, Kirshenbaum AS, Semere T, Worobec AS, Scott LM, Metcalfe DD. Akin C, et al. Among authors: metcalfe dd. Exp Hematol. 2000 Feb;28(2):140-7. doi: 10.1016/s0301-472x(99)00145-9. Exp Hematol. 2000. PMID: 10706069 Free article.

6

Mastocytosis complicating pregnancy.

Worobec AS, Akin C, Scott LM, Metcalfe DD. Worobec AS, et al. Among authors: metcalfe dd. Obstet Gynecol. 2000 Mar;95(3):391-5. doi: 10.1016/s0029-7844(99)00591-8. Obstet Gynecol. 2000. PMID: 10711550

7

Pediatric mastocytosis.

Hartmann K, Metcalfe DD. Hartmann K, et al. Among authors: metcalfe dd. Hematol Oncol Clin North Am. 2000 Jun;14(3):625-40. doi: 10.1016/s0889-8588(05)70299-9. Hematol Oncol Clin North Am. 2000. PMID: 10909043 Review.

8

Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology.

Akin C, Schwartz LB, Kitoh T, Obayashi H, Worobec AS, Scott LM, Metcalfe DD. Akin C, et al. Among authors: metcalfe dd. Blood. 2000 Aug 15;96(4):1267-73. Blood. 2000. PMID: 10942367 Free article. Clinical Trial.

9

Mastocytosis: molecular mechanisms and clinical disease heterogeneity.

Metcalfe DD, Akin C. Metcalfe DD, et al. Leuk Res. 2001 Jul;25(7):577-82. doi: 10.1016/s0145-2126(01)00046-7. Leuk Res. 2001. PMID: 11377683 Review.

10

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM. Valent P, et al. Among authors: metcalfe dd. Leuk Res. 2001 Jul;25(7):603-25. doi: 10.1016/s0145-2126(01)00038-8. Leuk Res. 2001. PMID: 11377686 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

528 results

Search Page